✦ LIBER ✦

Prognostic factors for cases with metastatic renal cell carcinoma in the era of targeted medicine

✍ Scribed by Yann Neuzillet; Stéphane Culine; Jean-Jacques Patard

Book ID: 108978020
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 87 KB
Volume: 16
Category: Article
ISSN: 0919-8172
DOI: 10.1111/j.1442-2042.2009.02365.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of metastatic renal cell carc

Management of metastatic renal cell carcinoma in the era of targeted therapies

✍ K. Webber; A. Cooper; H. Kleiven; D. Yip; D. Goldstein 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Thrombocytosis as a prognostic factor fo

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma

✍ Revathi Suppiah; Philip E. Shaheen; Paul Elson; Seema A. Misbah; Laura Wood; Rob 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 3 views

Role of Cytoreductive Nephrectomy in the

Role of Cytoreductive Nephrectomy in the Era of Targeted Therapy for Renal Cell Carcinoma

✍ Paul L. Crispen; Michael L. Blute 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 180 KB

The future of allogeneic hematopoietic s

The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy

✍ Ueno, N T; Cheng, Y C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 94 KB

The current role of immunotherapy for re

The current role of immunotherapy for renal cell carcinoma in the era of targeted therapeutics

✍ Michael K. K. Wong 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 123 KB

Phase 3 trial of everolimus for metastat

Phase 3 trial of everolimus for metastatic renal cell carcinoma : Final results and analysis of prognostic factors

✍ Robert J. Motzer; Bernard Escudier; Stephane Oudard; Thomas E. Hutson; Camillo P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views